Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

63/99

BSE: 532331 | NSE: AJANTPHARM

Watchlist

NSE BSE

2085.40

19-Apr-2024

Open
High
Low
Previous Close

2078.85
2107.95
2069.15
2078.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

34465
718.35
2353.95
1246.75

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

26,212.49
35.63
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

25,950.63
0.34%
7.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.97
12.73
9.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.82
6.70
-4.74

PAT CAGR (%)

10 Years
5 Years
3 Years

9.66
8.73
-3.48

P:E (Median)

8 Years
5 Years
3 Years

25.72
25.94
26.38

P:BV (Average)

8 Years
5 Years
3 Years

6.04
5.14
5.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.70
17.24
18.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 1,085.29 874.89 24.05% 945.18 837.23 12.89% 1,014.58 850.29 19.32% 848.86 765.63 10.87%
Expenses 758.11 715.48 5.96% 671.53 676.50 -0.73% 737.68 663.98 11.10% 704.33 578.48 21.76%
EBITDA 327.18 159.41 105.24% 273.65 160.73 70.25% 276.90 186.31 48.62% 144.53 187.15 -22.77%
EBIDTM 30.15% 18.22% 28.95% 19.20% 27.29% 21.91% 17.03% 24.44%
Other Income 13.73 30.51 -55.00% 52.16 78.37 -33.44% 31.46 35.42 -11.18% 36.75 28.42 29.31%
Interest 2.36 2.68 -11.94% 2.27 0.71 219.72% 0.75 0.63 19.05% 1.21 7.18 -83.15%
Depreciation 33.41 32.29 3.47% 33.04 31.80 3.90% 32.24 30.75 4.85% 32.11 30.09 6.71%
PBT 305.14 154.95 96.93% 290.50 206.59 40.62% 275.37 190.35 44.67% 147.96 178.30 -17.02%
Tax 84.99 30.99 174.25% 78.14 39.41 98.27% 63.33 39.98 58.40% 30.75 43.46 -29.25%
PAT 220.15 123.96 77.60% 212.36 167.18 27.02% 212.04 150.37 41.01% 117.21 134.84 -13.07%
PATM 20.28% 14.17% 22.47% 19.97% 20.90% 17.68% 13.81% 17.61%
EPS 17.49 9.85 77.56% 16.87 13.28 27.03% 16.84 11.94 41.04% 9.31 10.71 -13.07%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 1,105.15 971.77 13.73% 1,028.44 938.10 9.63% 1,021.04 950.93 7.37% 881.84 870.29 1.33%
Expenses 791.08 802.22 -1.39% 737.78 741.76 -0.54% 749.72 729.17 2.82% 732.47 663.60 10.38%
EBITDA 314.07 169.55 85.24% 290.66 196.34 48.04% 271.32 221.76 22.35% 149.37 206.69 -27.73%
EBIDTM 28.42% 17.45% 28.26% 20.93% 26.57% 23.32% 16.94% 23.75%
Other Income 13.59 34.93 -61.09% 21.33 40.35 -47.14% 31.75 32.76 -3.08% 36.83 29.48 24.93%
Interest 2.49 2.84 -12.32% 2.34 0.99 136.36% 0.85 0.88 -3.41% 1.13 7.34 -84.60%
Depreciation 34.26 33.30 2.88% 33.71 32.70 3.09% 33.18 31.78 4.41% 33.02 31.16 5.97%
PBT 290.91 168.34 72.81% 275.94 203.00 35.93% 269.04 221.86 21.27% 152.05 197.67 -23.08%
Tax 80.88 33.83 139.08% 80.64 46.40 73.79% 60.92 47.24 28.96% 29.80 46.46 -35.86%
PAT 210.03 134.51 56.14% 195.30 156.60 24.71% 208.12 174.62 19.18% 122.25 151.21 -19.15%
PATM 19.00% 13.84% 18.99% 16.69% 20.38% 18.36% 13.86% 17.37%
EPS 16.62 10.46 58.89% 15.46 12.18 26.93% 16.47 13.58 21.28% 9.68 11.74 -17.55%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,893.91 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35 1,804.33 1,558.21 1,356.20 1,109.92 Net Sales Growth 17.00% 8.62% 15.52% 23.77% 23.91% -2.89% 1.16% 15.80% 14.90% 22.19% Cost Of Goods Sold 1,104.63 824.32 679.10 600.59 546.67 304.80 311.26 348.99 318.31 306.55 285.50 Gross Profit 2,789.28 2,586.95 2,461.54 2,118.00 1,649.75 1,467.82 1,514.09 1,455.34 1,239.90 1,049.65 824.42 GP Margin 71.63% 75.84% 78.38% 77.91% 75.11% 82.81% 82.95% 80.66% 79.57% 77.40% 74.28% Total Expenditure 2,871.65 2,711.99 2,249.75 1,801.68 1,663.64 1,291.41 1,278.54 1,169.91 1,035.65 883.64 764.39 Power & Fuel Cost - 65.53 54.09 43.42 38.56 33.77 27.00 18.36 15.15 12.58 10.86 % Of Sales - 1.92% 1.72% 1.60% 1.76% 1.91% 1.48% 1.02% 0.97% 0.93% 0.98% Employee Cost - 720.41 585.87 498.11 437.82 389.37 342.89 269.78 235.03 186.34 147.25 % Of Sales - 21.12% 18.65% 18.32% 19.93% 21.97% 18.78% 14.95% 15.08% 13.74% 13.27% Manufacturing Exp. - 320.69 273.91 225.39 203.80 176.40 212.44 188.68 173.18 129.58 96.80 % Of Sales - 9.40% 8.72% 8.29% 9.28% 9.95% 11.64% 10.46% 11.11% 9.55% 8.72% General & Admin Exp. - 348.78 289.42 123.71 150.92 165.95 122.50 85.96 61.61 46.98 42.84 % Of Sales - 10.22% 9.22% 4.55% 6.87% 9.36% 6.71% 4.76% 3.95% 3.46% 3.86% Selling & Distn. Exp. - 354.87 316.58 248.70 225.44 178.54 173.75 161.51 164.06 154.44 140.19 % Of Sales - 10.40% 10.08% 9.15% 10.26% 10.07% 9.52% 8.95% 10.53% 11.39% 12.63% Miscellaneous Exp. - 77.39 50.78 61.76 60.43 42.58 88.70 96.63 68.31 47.17 140.19 % Of Sales - 2.27% 1.62% 2.27% 2.75% 2.40% 4.86% 5.36% 4.38% 3.48% 3.69% EBITDA 1,022.26 699.28 890.89 916.91 532.78 481.21 546.81 634.42 522.56 472.56 345.53 EBITDA Margin 26.25% 20.50% 28.37% 33.73% 24.26% 27.15% 29.96% 35.16% 33.54% 34.84% 31.13% Other Income 134.10 132.75 139.73 103.57 184.20 102.15 73.01 66.95 86.87 33.70 17.72 Interest 6.59 5.23 9.12 6.90 9.10 0.41 0.24 1.24 4.19 5.01 8.22 Depreciation 130.80 126.95 120.96 111.49 91.29 69.90 57.14 59.48 42.68 49.42 41.97 PBT 1,018.97 699.85 900.54 902.09 616.59 513.05 562.44 640.65 562.56 451.83 313.06 Tax 257.21 141.13 180.68 226.45 171.54 121.29 134.92 140.84 140.61 138.51 92.20 Tax Rate 25.24% 20.17% 20.06% 25.10% 28.00% 23.64% 23.99% 21.98% 24.99% 31.13% 29.45% PAT 761.76 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 220.86 PAT before Minority Interest 761.76 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 220.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.56% 16.38% 22.92% 24.85% 20.08% 22.10% 23.42% 27.70% 27.08% 22.59% 19.90% PAT Growth 32.17% -22.38% 6.54% 53.16% 12.60% -8.36% -14.46% 18.45% 37.73% 38.72% EPS 60.51 44.38 57.18 53.66 35.04 31.12 33.96 39.70 33.51 24.33 17.54

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 4,036.47 3,742.64 3,340.99 2,889.69 2,587.87 2,055.37 2,125.76 1,983.26 1,733.98 1,473.56 1,208.34 Net Sales Growth 8.18% 12.02% 15.62% 11.66% 25.91% -3.31% 7.19% 14.38% 17.67% 21.95% Cost Of Goods Sold 1,043.09 869.31 677.73 514.99 537.75 295.72 317.35 322.58 317.33 290.33 283.98 Gross Profit 2,993.38 2,873.33 2,663.26 2,374.70 2,050.12 1,759.65 1,808.41 1,660.68 1,416.65 1,183.23 924.36 GP Margin 74.16% 76.77% 79.71% 82.18% 79.22% 85.61% 85.07% 83.73% 81.70% 80.30% 76.50% Total Expenditure 3,011.05 2,959.39 2,411.70 1,891.13 1,904.55 1,488.94 1,467.37 1,296.38 1,146.92 968.33 839.59 Power & Fuel Cost - 65.71 54.38 43.70 38.88 32.65 27.42 18.70 15.49 12.91 11.20 % Of Sales - 1.76% 1.63% 1.51% 1.50% 1.59% 1.29% 0.94% 0.89% 0.88% 0.93% Employee Cost - 785.14 645.78 548.25 485.59 430.71 376.47 295.42 256.64 200.58 156.97 % Of Sales - 20.98% 19.33% 18.97% 18.76% 20.96% 17.71% 14.90% 14.80% 13.61% 12.99% Manufacturing Exp. - 320.81 275.42 226.20 204.81 174.78 215.80 192.70 174.40 130.81 96.29 % Of Sales - 8.57% 8.24% 7.83% 7.91% 8.50% 10.15% 9.72% 10.06% 8.88% 7.97% General & Admin Exp. - 365.86 300.83 131.64 159.49 149.90 131.92 92.02 66.24 50.99 47.40 % Of Sales - 9.78% 9.00% 4.56% 6.16% 7.29% 6.21% 4.64% 3.82% 3.46% 3.92% Selling & Distn. Exp. - 463.94 400.29 374.73 413.70 320.99 306.30 270.92 245.92 233.96 201.57 % Of Sales - 12.40% 11.98% 12.97% 15.99% 15.62% 14.41% 13.66% 14.18% 15.88% 16.68% Miscellaneous Exp. - 88.62 57.27 51.62 64.33 84.19 92.11 104.04 70.90 48.75 201.57 % Of Sales - 2.37% 1.71% 1.79% 2.49% 4.10% 4.33% 5.25% 4.09% 3.31% 3.49% EBITDA 1,025.42 783.25 929.29 998.56 683.32 566.43 658.39 686.88 587.06 505.23 368.75 EBITDA Margin 25.40% 20.93% 27.81% 34.56% 26.40% 27.56% 30.97% 34.63% 33.86% 34.29% 30.52% Other Income 103.50 98.64 115.68 25.98 92.19 21.08 24.16 23.86 21.15 16.80 13.71 Interest 6.81 5.84 10.20 8.27 11.91 1.16 0.41 1.36 4.89 5.92 8.73 Depreciation 134.17 130.80 125.29 116.09 95.71 72.08 59.59 61.21 44.43 51.64 43.88 PBT 987.94 745.25 909.48 900.18 667.89 514.27 622.55 648.17 558.89 464.47 329.85 Tax 252.24 157.27 196.80 246.31 196.27 127.30 153.91 141.34 143.28 146.15 95.97 Tax Rate 25.53% 21.10% 21.64% 27.36% 29.56% 24.75% 24.72% 21.81% 25.64% 32.05% 29.10% PAT 735.70 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 233.88 PAT before Minority Interest 735.70 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 233.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.23% 15.71% 21.33% 22.63% 18.07% 18.83% 22.05% 25.56% 23.97% 21.03% 19.36% PAT Growth 19.25% -17.50% 8.99% 39.81% 20.86% -17.43% -7.54% 21.95% 34.13% 32.49% EPS 58.44 46.70 56.61 51.94 37.15 30.74 37.22 40.26 33.01 24.61 18.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 3,246.45 3,169.18 2,884.98 2,461.30 2,142.08 1,931.50 1,503.94 1,131.70 786.33 536.32 Share Capital 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 17.67 Total Reserves 3,220.84 3,151.71 2,867.04 2,443.29 2,123.44 1,912.18 1,486.25 1,114.01 768.22 518.08 Non-Current Liabilities 272.90 338.33 321.18 252.27 193.38 60.16 32.36 40.44 54.69 79.59 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.73 22.32 40.51 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.09 9.95 10.77 Long Term Provisions 146.55 216.04 208.12 155.01 134.15 13.16 4.89 2.59 4.76 2.83 Current Liabilities 907.84 469.70 706.28 614.30 427.47 300.19 212.24 241.55 244.83 263.96 Trade Payables 353.02 274.37 317.20 302.77 185.53 211.47 145.31 145.04 108.12 110.90 Other Current Liabilities 529.32 176.59 152.32 153.28 113.56 68.01 46.09 50.68 54.51 49.81 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.47 17.90 60.54 Short Term Provisions 25.50 18.74 236.76 158.25 128.38 20.71 20.84 11.36 64.30 42.71 Total Liabilities 4,427.19 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85 879.87 Net Block 1,484.01 1,483.91 1,518.79 1,449.32 1,152.14 1,036.69 572.93 432.83 271.32 261.40 Gross Block 2,246.28 2,152.24 2,086.53 1,926.64 1,540.50 1,379.38 859.28 679.21 510.92 449.57 Accumulated Depreciation 762.27 668.33 567.74 477.32 388.36 342.69 286.35 246.38 239.60 188.17 Non Current Assets 1,876.00 1,920.20 1,886.04 1,773.43 1,593.76 1,196.84 973.47 715.27 512.82 426.22 Capital Work in Progress 209.47 152.86 108.19 131.06 261.29 61.33 254.22 198.91 170.20 93.55 Non Current Investment 42.99 42.99 17.89 18.63 28.14 18.26 17.26 17.25 57.16 23.84 Long Term Loans & Adv. 134.68 226.15 230.52 163.96 139.91 66.38 34.93 21.12 8.87 38.68 Other Non Current Assets 4.85 5.88 10.65 10.46 12.28 14.18 9.09 4.27 5.27 8.75 Current Assets 2,543.27 2,057.01 2,026.40 1,554.44 1,169.17 1,095.01 775.07 698.42 573.03 453.65 Current Investments 510.27 121.86 138.99 67.14 64.74 182.38 181.56 76.78 19.46 55.00 Inventories 683.77 635.11 634.22 436.19 414.26 317.37 179.28 189.78 153.05 148.77 Sundry Debtors 977.63 1,043.62 782.30 734.24 423.38 432.19 336.00 350.48 240.85 177.09 Cash & Bank 269.92 145.25 151.98 87.85 35.87 38.67 22.84 21.44 105.69 29.08 Other Current Assets 101.68 29.78 99.10 65.39 230.92 124.40 55.39 59.94 53.98 43.71 Short Term Loans & Adv. 83.12 81.39 219.81 163.63 137.20 12.71 48.26 53.75 42.01 40.33 Net Current Assets 1,635.43 1,587.31 1,320.12 940.14 741.70 794.82 562.83 456.87 328.20 189.69 Total Assets 4,419.27 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85 879.87

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 3,387.99 3,264.34 2,995.63 2,598.87 2,245.21 2,041.37 1,567.69 1,190.86 841.09 593.31 Share Capital 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 17.67 Total Reserves 3,362.38 3,246.87 2,977.70 2,580.86 2,226.57 2,022.05 1,550.00 1,173.17 822.98 575.06 Non-Current Liabilities 177.38 285.02 274.55 227.61 162.23 38.56 8.90 28.63 55.67 80.62 Secured Loans 1.25 1.64 1.60 0.74 0.66 1.01 1.04 5.79 23.31 41.53 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.08 9.94 10.77 Long Term Provisions 146.55 216.04 208.12 155.01 134.15 13.16 4.88 2.59 4.76 2.83 Current Liabilities 1,139.28 647.39 838.82 745.53 498.35 346.05 246.66 259.89 249.59 275.42 Trade Payables 422.77 327.17 373.86 362.34 225.18 249.63 178.18 145.57 109.06 124.54 Other Current Liabilities 669.42 301.47 214.14 180.12 111.45 63.95 46.33 56.72 58.33 47.63 Short Term Borrowings 0.00 0.00 0.00 42.85 33.34 0.00 0.00 46.25 17.90 60.55 Short Term Provisions 47.09 18.75 250.82 160.22 128.38 32.47 22.15 11.35 64.30 42.70 Total Liabilities 4,704.65 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35 949.35 Net Block 1,496.44 1,503.58 1,541.11 1,472.14 1,168.35 1,052.66 589.17 450.74 288.09 279.39 Gross Block 2,282.82 2,206.86 2,140.80 1,976.15 1,578.96 1,417.23 894.94 715.73 549.85 492.00 Accumulated Depreciation 786.38 703.28 599.69 504.01 410.61 364.57 305.77 264.99 261.76 212.61 Non Current Assets 1,870.65 1,932.29 1,891.22 1,790.94 1,605.27 1,202.36 972.65 716.11 512.94 429.30 Capital Work in Progress 209.47 152.86 108.19 131.86 261.61 61.33 254.22 198.91 170.20 93.55 Non Current Investment 25.10 25.10 0.00 12.28 22.87 7.58 0.00 0.00 40.04 8.46 Long Term Loans & Adv. 134.79 236.46 230.74 164.20 148.36 76.79 41.88 21.29 9.34 39.15 Other Non Current Assets 4.85 5.88 11.18 10.46 4.08 4.00 2.34 4.28 5.27 8.75 Current Assets 2,825.18 2,264.46 2,217.78 1,781.07 1,300.52 1,223.62 850.60 763.27 633.41 520.05 Current Investments 510.27 121.86 175.67 67.14 64.74 182.38 181.56 76.78 19.46 55.00 Inventories 815.63 791.07 766.47 495.68 435.71 350.63 211.02 204.58 159.03 155.40 Sundry Debtors 1,056.90 1,019.81 738.43 775.30 459.48 459.79 323.15 372.35 258.76 202.22 Cash & Bank 330.90 211.79 209.61 205.25 100.51 93.09 69.95 43.37 136.76 60.39 Other Current Assets 111.48 34.79 104.15 69.02 240.08 137.73 64.92 66.19 59.40 47.04 Short Term Loans & Adv. 89.39 85.14 223.45 168.68 143.45 23.11 56.29 59.39 47.43 43.66 Net Current Assets 1,685.90 1,617.07 1,378.96 1,035.54 802.17 877.57 603.94 503.38 383.82 244.63 Total Assets 4,695.83 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35 949.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 736.29 542.34 466.99 300.88 311.82 219.17 536.90 276.67 262.92 189.71 PBT 699.85 900.54 902.09 612.67 513.05 562.44 640.65 562.56 444.88 313.06 Adjustment 79.34 55.58 37.07 -36.60 -11.56 0.21 40.16 -21.87 34.18 34.49 Changes in Working Capital 82.66 -220.31 -274.26 -136.66 -86.64 -221.02 -13.32 -111.94 -80.75 -68.15 Cash after chg. in Working capital 861.85 735.81 664.90 439.41 414.85 341.63 667.49 428.75 398.31 279.40 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -125.56 -193.47 -197.91 -138.53 -103.03 -122.46 -130.59 -152.08 -135.39 -89.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -501.31 -66.04 -162.68 -115.91 -136.88 -201.13 -339.66 -139.39 -145.63 -175.57 Net Fixed Assets -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 -120.60 Net Investments -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 -59.98 Others 37.75 52.31 45.45 132.89 116.44 127.90 0.51 75.02 -9.85 5.01 Cash from Financing Activity -105.12 -457.30 -268.90 -134.00 -180.89 -0.54 -198.02 -128.38 -101.18 -19.80 Net Cash Inflow / Outflow 129.86 19.00 35.41 50.97 -5.95 17.50 -0.78 8.90 16.11 -5.66 Opening Cash & Equivalents 139.83 119.88 84.95 30.52 36.22 18.72 19.49 10.59 7.30 12.96 Closing Cash & Equivalent 269.69 138.88 120.36 81.49 30.27 36.22 18.71 19.49 23.41 7.30

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 791.78 561.71 576.31 456.77 374.51 281.12 609.29 326.14 279.42 212.42 PBT 745.25 909.48 900.18 663.97 514.27 622.56 648.17 558.90 456.01 329.85 Adjustment 131.30 91.75 115.27 70.79 61.93 52.48 86.33 53.07 51.21 50.82 Changes in Working Capital 66.52 -200.39 -208.75 -123.16 -83.46 -254.32 25.88 -124.34 -81.69 -74.52 Cash after chg. in Working capital 943.07 800.84 806.70 611.60 492.74 420.72 760.38 487.63 425.53 306.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -151.29 -239.13 -230.39 -154.83 -118.23 -139.60 -151.09 -161.49 -146.11 -93.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -559.60 -74.10 -282.38 -224.40 -222.78 -256.11 -383.12 -209.07 -158.36 -187.80 Net Fixed Assets -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 -120.60 Net Investments -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 -59.98 Others -20.54 44.25 -74.25 24.40 30.54 72.92 -42.95 5.34 -22.58 -7.22 Cash from Financing Activity -107.87 -459.71 -318.29 -128.63 -147.46 -0.20 -201.77 -117.32 -105.19 -20.13 Net Cash Inflow / Outflow 124.31 27.90 -24.36 103.74 4.27 24.81 24.40 -0.25 15.87 4.49 Opening Cash & Equivalents 206.36 177.51 202.35 95.16 90.64 65.83 41.42 41.67 38.62 34.13 Closing Cash & Equivalent 330.67 205.41 177.99 198.90 94.91 90.64 65.82 41.42 54.49 38.62

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 257.83 247.37 222.30 282.03 245.37 219.29 170.89 128.59 89.35 60.94 ROA 13.30% 18.25% 18.66% 14.49% 15.50% 21.16% 31.61% 33.76% 31.17% 28.40% ROE 17.42% 23.78% 25.28% 19.17% 19.25% 24.90% 37.93% 44.01% 46.37% 49.56% ROCE 21.98% 30.05% 34.00% 27.01% 25.21% 32.76% 47.50% 55.13% 59.10% 56.12% Fixed Asset Turnover 1.58 1.50 1.37 1.27 1.21 1.64 2.37 2.64 2.85 2.60 Receivable days 106.35 104.55 100.41 96.19 88.09 76.59 68.73 68.58 55.76 51.00 Inventory Days 69.39 72.68 70.87 70.66 75.32 49.52 36.95 39.76 40.27 47.73 Payable days 138.90 158.98 188.39 57.84 60.10 55.05 50.18 46.47 47.80 61.39 Cash Conversion Cycle 36.84 18.26 -17.11 109.01 103.31 71.06 55.51 61.87 48.23 37.33 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.09 0.24 Interest Cover 134.81 99.74 131.74 68.33 1252.34 2344.50 517.65 135.26 89.80 39.09

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 269.07 254.80 230.83 297.80 257.19 231.78 178.14 135.31 95.57 67.42 ROA 13.21% 17.16% 17.03% 14.44% 14.52% 22.06% 30.69% 31.66% 29.57% 28.05% ROE 17.68% 22.77% 23.38% 19.32% 18.07% 25.98% 36.75% 40.92% 43.24% 47.47% ROCE 22.57% 29.37% 32.20% 27.44% 23.84% 34.49% 45.74% 51.61% 56.43% 54.53% Fixed Asset Turnover 1.69 1.56 1.43 1.46 1.37 1.84 2.49 2.76 2.85 2.61 Receivable days 99.85 94.50 93.66 87.08 81.62 67.06 63.41 65.84 56.64 52.93 Inventory Days 77.25 83.71 78.09 65.68 69.82 48.10 37.89 37.93 38.64 45.48 Payable days 157.44 188.77 260.89 59.55 63.24 57.26 50.30 41.91 46.38 59.31 Cash Conversion Cycle 19.66 -10.56 -89.14 93.21 88.21 57.90 51.01 61.86 48.91 39.10 Total Debt/Equity 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.07 0.09 0.22 Interest Cover 128.61 90.16 109.85 56.75 444.34 1519.41 477.60 115.29 78.03 38.78

Top Investors:

uti flexi cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

kotak small cap fund

hdfc large and mid cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ajanta Pharma - Quarterly Results
31st Jan 2024, 16:12 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback